Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: FULGENT THERAPEUTICS LLC
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2021-03-11 to 2022-03-10
Current total value of award: $40517395
Description: SARS-COV-2 GENOMIC SEQUENCING